文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

配准PET与动态增强CT的参数反应映射识别局部晚期宫颈癌放射抵抗亚体积

Parametric Response Mapping of Coregistered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radioresistant Subvolumes in Locally Advanced Cervical Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-04-03

本研究对21例局部晚期宫颈癌患者进行同步放化疗前及治疗中(23±4天)的PET与DCE CT配准成像,利用参数反应映射(PRM)将肿瘤体素分为四类亚体积。结果显示三个PRM亚体积在治疗中显著变化,且PRM SUVloBFlo是预测代谢肿瘤体积相对变化(ΔMTV)的唯一独立显著变量,提示其可识别放射抵抗亚体积并辅助临床决策。

要点

  • PRM可基于PET SUV与DCE CT血流将肿瘤分为四个代谢-灌注亚体积。

核心结论

  • PRM可识别局部晚期宫颈癌中与代谢肿瘤体积变化相关、预测治疗反应的放射抵抗亚体积。
  • 识别这些亚体积可能辅助临床决策以调整近距离放疗等治疗。

研究设计与样本

  • 前瞻性 pilot 研究(NCT01805141)纳入21例局部晚期宫颈癌患者。
  • 在同步放化疗前及治疗中(23±4天)行DCE CT和PET成像,生成配准的SUV与血流三维图谱。
  • 采用体素级联合直方图分析进行PRM,基于治疗前群体均值阈值分类四个亚体积。
  • 用单变量和多变量线性回归分析基线影像指标与ΔMTV的关系。

关键数值与推荐

  • PRM分类阈值基于治疗前PET SUV和DCE CT BF的群体均值确定。
  • 亚体积定义:SUVhiBFhi(高代谢高灌注)、SUVhiBFlo(高代谢低灌注/缺氧)、SUVloBFlo(低代谢低灌注/缺氧)、SUVloBFhi(低代谢高灌注)。

临床怎么用

  • 可利用治疗前及治疗中PET/DCE CT配准成像进行PRM分析,识别放射抵抗亚体积。
  • PRM SUVloBFlo或可辅助预测宫颈癌放化疗后代谢肿瘤体积变化,指导个体化治疗调整。

局限性

  • 样本量较小(21例),为 pilot 研究。
  • PRM阈值基于群体均值,需进一步验证。
  • 研究未报告长期临床结局与PRM亚体积的直接关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify subvolumes that may predict treatment response to definitive concurrent chemoradiation therapy using parametric response mapping (PRM) of coregistered positron emission tomography (PET) and dynamic contrast-enhanced (DCE) computed tomography (CT) in locally advanced cervical carcinoma. METHODS AND MATERIALS: Pre- and midtreatment (after 23 ± 4 days of concurrent chemoradiation therapy) DCE CT and PET imaging were performed on 21 patients with cervical cancer who were enrolled in a pilot study to evaluate the prognostic value of CT perfusion for primary cervical cancer (NCT01805141). Three-dimensional coregistered maps of PET/CT standardized uptake value (SUV) and DCE CT blood flow (BF) were generated. PRM was performed using voxel-wise joint histogram analysis to classify voxels within the tumor as highly metabolic and perfused (SUVhiBFhi), highly metabolic and hypoxic (SUVhiBFlo), low metabolic activity and hypoxic (SUVloBFlo), or low metabolic activity and perfused (SUVloBFhi) tissue based on thresholds determined from population means of pretreatment PET SUV and DCE CT BF. Relationships between baseline pretreatment imaging metrics and relative changes in metabolic tumor volume (ΔMTV), calculated from before treatment and during treatment imaging, were determined using univariable and multivariable linear regression models. RESULTS: The relative volume of three PRM subvolumes significantly changed during treatment (SUVhiBFhi: P = .04; SUVhiBFlo: P = .0008; SUVloBFhi: P = .02), whereas SUVloBFlo did not (P = .9). Pretreatment PET SUVmax (r = -.58, P = .006), PET SUVmean (ρ = -.59, P = .005), DCE CT BFmean (r = -.50, P = .02), tumor volume (ρ = -.65, P = .001) and PRM SUVhiBFhi (ρ = -.59, P = .004) were negatively correlated with ΔMTV, whereas PRM SUVloBFlo was positively related to ΔMTV (r = .77, P < .0001). In a multivariable model that predicted ΔMTV, PRM SUVloBFlo, which combines both PET/CT and DCE CT, was the only significant variable (β = 1.825, P = .03), dominating both imaging modalities independently. CONCLUSIONS: PRM was applied in locally advanced cervical carcinoma treated definitively with chemoradiation, and radioresistant subvolumes were identified that correlated with changes in MTV and predicted treatment response. Identification of these subvolumes may assist in clinical decision making to tailor therapies, such as brachytherapy, in an effort to improve patient outcomes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Capaldi DPI, Hristov DH, Kidd EA, et al. Parametric Response Mapping of Coregistered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radioresistant Subvolumes in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32251757. doi:10.1016/j.ijrobp.2020.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。